CIK 0000883107 · Non-accelerated filer<br>Smaller reporting company
SOLESENCE, INC.
Sign in to watch- Ticker
- SLSN
- Exchange
- Nasdaq
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363687863
- Phone
- 6307716078
- Business address
- 1319 MARQUETTE DRIVE, ROMEOVILLE, IL, 60446
- Former names
- NANOPHASE TECHNOLOGIES Corp, NANOPHASE TECHNOLOGIES CORPORATION
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-28 | WHITMORE R JANET Director | Grant or award · Common Stock (right to purchase) | +20,000 | $4.17 | $83K | 20,000 |
| 2021-12-28 | SIEGEL RICHARD W Director | Grant or award · Common Stock (right to purchase) | +15,000 | $4.17 | $63K | 15,000 |
| 2021-12-28 | Beres Laura M Director | Grant or award · Common Stock (option to purchase) | +15,000 | $4.17 | $63K | 15,000 |
| 2021-12-28 | WHITMORE R JANET Director | Grant or award · Common Stock (right to purchase) | +20,000 | $4.17 | $83K | 20,000 |
| 2021-12-28 | Cureton Kevin Chief Operating Officer | Grant or award · Common Stock (right to purchase) | +90,000 | $4.17 | $375K | 90,000 |
| 2021-12-28 | JANKOWSKI JESS President, CEO | Grant or award · Common Stock (right to purchase) | +90,000 | $4.17 | $375K | 90,000 |
| 2021-12-21 | WHITMORE BRADFORD T 10% owner | Sale | −7,731,573 | $4.19 | $32.4M | 21,893,717 |
| 2021-12-21 | WHITMORE BRADFORD T 10% owner | Purchase | +7,731,573 | $4.19 | $32.4M | 7,731,573 |
| 2021-11-30 | Cureton Kevin Chief Operating Officer | Option exercise | +24,000 | $0.42 | $10K | 49,650 |
| 2021-11-30 | Cureton Kevin Chief Operating Officer | Option exercise | +25,000 | $0.52 | $13K | 74,650 |
| 2021-11-30 | Cureton Kevin Chief Operating Officer | Sale | −23,829 | $3.79 | $90K | 50,821 |
| 2021-11-30 | Cureton Kevin Chief Operating Officer | Option exercise · Common Stock (right to purchase) | −24,000 | $0.42 | $10K | 0 |
| 2021-11-30 | Cureton Kevin Chief Operating Officer | Option exercise · Common Stock (right to purchase) | −25,000 | $0.52 | $13K | 25,000 |
| 2021-11-26 | Cureton Kevin Chief Operating Officer | Option exercise | +12,607 | $0.52 | $7K | 38,257 |
| 2021-11-26 | Cureton Kevin Chief Operating Officer | Sale | −12,607 | $3.50 | $44K | 25,650 |
| 2021-11-26 | Cureton Kevin Chief Operating Officer | Option exercise · Common Stock | −12,607 | $0.52 | $7K | 0 |
| 2021-11-24 | Cureton Kevin Chief Operating Officer | Option exercise | +12,332 | $0.42 | $5K | 37,982 |
| 2021-11-24 | Cureton Kevin Chief Operating Officer | Option exercise | +12,393 | $0.52 | $6K | 50,375 |
| 2021-11-24 | Cureton Kevin Chief Operating Officer | Sale | −24,725 | $3.77 | $93K | 25,650 |
| 2021-11-24 | Cureton Kevin Chief Operating Officer | Option exercise · Common Stock (right to purchase) | −12,332 | $0.42 | $5K | 24,000 |
Page 17 of 19 · 367 trades